POPULATION PHARMACOKINETIC ANALYSIS OF RILZABRUTINIB IN HEALTHY SUBJECTS AND PATIENTS WITH PEMPHIGUS.

被引：0
|
作者：
Ge, S. [1 ]
Li, M. [1 ]
Lu, Q. [1 ]
Katragadda, S. [1 ]
机构：
[1] Sanofi, Bridgewater, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EP-019
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [31] Population pharmacokinetic analysis of pirmenol in healthy volunteers and patients with arrhythmia
    H. Kasai
    K. Ueno
    M. Kusumoto
    M. Shibakawa
    European Journal of Clinical Pharmacology, 1999, 55 : 77 - 78
  • [32] Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's disease
    Agbo, Felix
    Crass, Ryan L.
    Chiu, Yu-Yuan
    Chapel, Sunny
    Galluppi, Gerald
    Blum, David
    Navia, Bradford
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1464 - 1475
  • [33] Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis
    Cao, Yuran
    Li, Yi
    Guo, Beining
    Zhang, Jing
    Wu, Xiaojie
    Yu, Jicheng
    Cao, Guoying
    Fan, Yaxin
    Wu, Hailan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (04)
  • [34] Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach
    Adehin, Ayorinde
    Igbinoba, Sharon I.
    Soyinka, Julius O.
    Onyeji, Cyprian O.
    Babalola, Chinedum P.
    Bolaji, Oluseye O.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2019, 91 : 33 - 38
  • [35] Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors
    Yin, Ophelia
    Wagner, Andrew J.
    Kang, Jia
    Knebel, William
    Zahir, Hamim
    van de Sande, Michiel
    Tap, William D.
    Gelderblom, Hans
    Healey, John H.
    Shuster, Dale
    Stacchiotti, Silvia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (04): : 480 - 492
  • [36] Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
    Fediuk, Daryl J.
    Zhou, Susan
    Dawra, Vikas Kumar
    Sahasrabudhe, Vaishali
    Sweeney, Kevin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 696 - 706
  • [37] Population Pharmacokinetic Modeling for Mirogabalin in Healthy Subjects and Patients with Diabetic Peripheral Neuropathic Pain
    Yin, Ophelia
    Song, Saeheum
    Truitt, Kenneth
    Miller, Raymond
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S48 - S48
  • [38] Population pharmacokinetic analysis of clopidogrel in healthy Jordanian subjects with emphasis optimal sampling strategy
    Yousef, A. M.
    Melhem, M.
    Xue, B.
    Arafat, T.
    Reynolds, D. K.
    Van Wart, S. A.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (04) : 215 - 226
  • [39] Population pharmacokinetic analysis of dapagliflozin in healthy and subjects with type 2 diabetes mellitus.
    Feng, Y.
    Zhang, L.
    Komoroski, B.
    Pfister, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S93 - S93
  • [40] POPULATION PHARMACOKINETIC ANALYSIS OF SPARSENTAN IN HEALTHY VOLUNTEERS AND SUBJECTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS).
    Chen, S.
    Wada, R.
    Zhang, L.
    Kleijn, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S14 - S14
12345